Index RUT P/E - EPS (ttm) -0.16 Insider Own 5.54% Shs Outstand 45.51M Perf Week 4.39%
Market Cap 497.80M Forward P/E 23.01 EPS next Y 0.47 Insider Trans -3.59% Shs Float 43.02M Perf Month -3.79%
Enterprise Value 538.17M PEG - EPS next Q 0.06 Inst Own 86.42% Short Float 5.27% Perf Quarter -38.21%
Income -7.16M P/S 2.56 EPS this Y 60.71% Inst Trans 8.67% Short Ratio 3.69 Perf Half Y -33.72%
Sales 194.52M P/B 4.72 EPS next Y 127.35% ROA -3.74% Short Interest 2.27M Perf YTD -33.68%
Book/sh 2.32 P/C 17.73 EPS next 5Y 86.26% ROE -7.22% 52W High 21.00 -47.95% Perf Year 41.76%
Cash/sh 0.62 P/FCF 418.32 EPS past 3/5Y 29.94% 21.24%ROIC -4.17% 52W Low 7.23 51.18% Perf 3Y 25.92%
Dividend Est. - EV/EBITDA 73.32 Sales past 3/5Y 13.73% 11.91% Gross Margin 74.18% Volatility 4.50% 4.97% Perf 5Y 21.44%
Dividend TTM - EV/Sales 2.77 EPS Y/Y TTM 67.41% Oper. Margin -0.25% ATR (14) 0.55 Perf 10Y 244.79%
Dividend Ex-Date Jan 27, 2010 Quick Ratio 2.65 Sales Y/Y TTM 18.81% Profit Margin -3.68% RSI (14) 50.86 Recom 1.12
Dividend Gr. 3/5Y - - Current Ratio 4.28 EPS Q/Q 44.76% SMA20 6.10% Beta 0.98 Target Price 24.25
Payout - Debt/Eq 0.65 Sales Q/Q 17.36% SMA50 -9.22% Rel Volume 0.28 Prev Close 11.06
Employees 452 LT Debt/Eq 0.63 Earnings May 08 BMO SMA200 -26.90% Avg Volume 613.66K Price 10.93
IPO Dec 17, 1986 Option/Short Yes / Yes EPS/Sales Surpr. -236.99% 0.53% Trades
Volume 169,683 Change -1.18%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-17-25 Initiated Lake Street
Buy
$30
Jul-01-24 Initiated Raymond James
Outperform
$13
Nov-11-22 Resumed Jefferies
Buy
$15
May-09-22 Upgrade Canaccord Genuity
Hold → Buy
$10 → $15
Mar-11-22 Resumed Cantor Fitzgerald
Overweight
$21
Oct-23-20 Initiated Guggenheim
Buy
$24
Jun-16-20 Resumed Cantor Fitzgerald
Overweight
$16
May-07-20 Downgrade Canaccord Genuity
Buy → Hold
$12
Apr-02-20 Downgrade BTIG Research
Buy → Neutral
Aug-07-19 Downgrade William Blair
Outperform → Mkt Perform
Jul-12-19 Initiated Canaccord Genuity
Buy
$32
Mar-02-18 Reiterated Lake Street
Buy
$26 → $38
Jan-05-18 Resumed Cantor Fitzgerald
Overweight
Nov-30-17 Initiated Jefferies
Buy
$35
Nov-21-17 Reiterated Lake Street
Buy
$22 → $26
Jul-31-17 Initiated Leerink Partners
Outperform
$22
Jun-30-17 Initiated Cantor Fitzgerald
Overweight
$18
Mar-06-17 Initiated ROTH Capital
Buy
$14.50
Nov-22-16 Upgrade Lake Street
Hold → Buy
$9 → $11
Nov-07-16 Reiterated Wedbush
Outperform
$10 → $12
Show Previous Ratings
Jul-02-25 10:06PM
May-28-25 08:00AM
May-21-25 09:35AM
May-09-25 09:45AM
09:30AM
03:08AM
Loading…
03:08AM
May-08-25 08:30AM
07:28AM
(Associated Press Finance)
07:05AM
07:00AM
May-07-25 06:00PM
01:09PM
12:31PM
May-02-25 01:22PM
01:21PM
08:04AM
Loading…
Apr-24-25 08:04AM
Mar-31-25 03:03PM
(Investor's Business Daily)
Mar-25-25 11:12AM
Mar-24-25 08:00AM
Mar-04-25 03:04PM
(Investor's Business Daily)
Feb-26-25 02:03AM
12:27AM
(Thomson Reuters StreetEvents)
Feb-25-25 07:41AM
(Associated Press Finance) +11.66%
07:10AM
07:00AM
Feb-11-25 04:58PM
Feb-03-25 08:00AM
Jan-13-25 09:35AM
05:05AM
Jan-10-25 05:00PM
08:00AM
Loading…
08:00AM
Dec-24-24 09:15AM
Dec-19-24 09:40AM
Nov-28-24 12:00PM
Nov-25-24 09:55AM
Nov-08-24 07:35AM
02:08AM
Nov-07-24 07:48AM
(Associated Press Finance) -13.44%
07:00AM
Oct-24-24 07:00AM
Oct-14-24 07:21AM
Oct-09-24 05:30PM
Sep-12-24 01:30AM
Sep-06-24 07:00AM
Sep-04-24 09:15AM
Sep-03-24 07:00AM
Aug-30-24 12:00PM
Aug-23-24 09:55AM
Aug-19-24 09:15AM
Aug-13-24 04:18PM
Aug-09-24 12:56AM
Aug-08-24 08:20AM
07:19AM
(Associated Press Finance)
07:05AM
07:00AM
Aug-01-24 10:01AM
Jul-23-24 07:00AM
Jul-12-24 08:37AM
Jul-01-24 07:00AM
Jun-25-24 12:52PM
Jun-24-24 07:00AM
Jun-12-24 04:56AM
May-28-24 04:30PM
May-17-24 12:29PM
May-16-24 02:56PM
07:00AM
May-14-24 07:00AM
May-06-24 10:31AM
May-03-24 03:02AM
May-02-24 11:57AM
08:15AM
07:14AM
(Associated Press Finance)
07:00AM
Apr-29-24 04:50PM
Apr-16-24 07:00AM
Mar-08-24 11:55PM
Mar-06-24 08:20AM
Mar-05-24 09:27PM
(Thomson Reuters StreetEvents) -15.11%
11:53AM
07:38AM
(Associated Press Finance)
07:31AM
07:00AM
Feb-28-24 08:50AM
Feb-26-24 09:15AM
Feb-13-24 04:30PM
Feb-12-24 08:50AM
Feb-06-24 09:40AM
Feb-02-24 04:15PM
Jan-26-24 08:50AM
Jan-18-24 05:00PM
Jan-04-24 04:45PM
04:40PM
04:35PM
Dec-26-23 04:15PM
Dec-06-23 07:00AM
Dec-01-23 05:00PM
Nov-20-23 07:00AM
Nov-08-23 09:41AM
Nov-07-23 11:01PM
(Thomson Reuters StreetEvents) +36.90%
08:04AM
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm's products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Weiler Kathy Johnson Director Jun 09 '25 Sale 10.61 4,073 43,215 6,580 Jun 11 04:27 PM Levine Alan M Director Jun 09 '25 Sale 10.61 4,073 43,215 36,743 Jun 11 04:26 PM Wendell Amy McBride Director Jun 09 '25 Sale 10.61 4,073 43,215 93,826 Jun 11 04:26 PM Burke William P. Mr. Director Jun 09 '25 Sale 10.61 4,073 43,215 24,484 Jun 11 04:25 PM NEELS GUIDO J Director Jun 09 '25 Sale 10.61 4,073 43,215 86,743 Jun 11 04:24 PM JOHNSON JOHN Director Jun 09 '25 Sale 10.61 4,073 43,215 24,943 Jun 11 04:23 PM TYNDALL JOSEPH A. Director Jun 10 '25 Option Exercise 6.56 11,586 75,952 26,931 Jun 11 04:22 PM TYNDALL JOSEPH A. Director Jun 10 '25 Sale 10.72 26,931 288,700 0 Jun 11 04:22 PM JOSEPH A TYNDALL Director Jun 10 '25 Proposed Sale 10.72 26,931 288,814 Jun 10 05:41 PM TYNDALL JOSEPH A. Director May 22 '25 Option Exercise 6.30 12,850 80,955 35,407 May 23 04:32 PM TYNDALL JOSEPH A. Director May 22 '25 Sale 11.20 20,062 224,694 15,345 May 23 04:32 PM TYNDALL JOSEPH A. Director May 19 '25 Sale 11.63 2,525 29,366 22,557 May 23 04:12 PM TYNDALL JOSEPH A. Director May 22 '25 Proposed Sale 11.15 32,339 360,580 May 22 05:14 PM DeVinney Erick Wayne Chief Innovation Officer Mar 16 '25 Option Exercise 0.00 32,462 0 232,873 Mar 19 05:24 PM DeVinney Erick Wayne Chief Innovation Officer Mar 19 '25 Sale 17.50 15,111 264,442 217,762 Mar 19 05:24 PM Began Marc A EVP & General Counsel Mar 01 '25 Option Exercise 0.00 22,500 0 24,186 Mar 05 06:24 PM Wendell Amy McBride Director Mar 03 '25 Sale 20.02 5,000 100,100 97,899 Mar 05 06:20 PM DeVinney Erick Wayne Chief Innovation Officer Feb 28 '25 Option Exercise 0.00 24,799 0 209,301 Mar 04 07:22 PM AMY MCBRIDE-WENDELL Director Mar 03 '25 Proposed Sale 20.01 5,000 100,050 Mar 03 04:16 PM Kemp Jens Chief Marketing Officer Feb 22 '25 Option Exercise 0.00 2,500 0 2,500 Feb 26 04:25 PM Zaderej Karen L. SENIOR ADVISOR Jan 21 '25 Proposed Sale 18.41 220,000 4,050,000 Jan 21 01:20 PM Zaderej Karen L. SENIOR ADVISOR Jan 14 '25 Proposed Sale 18.00 100,000 1,800,000 Jan 14 01:24 PM Zaderej Karen L. SENIOR ADVISOR Nov 07 '24 Proposed Sale 12.71 70,000 890,000 Nov 07 10:52 AM Zaderej Karen L. SENIOR ADVISOR Sep 05 '24 Proposed Sale 13.00 150,000 1,950,000 Sep 05 04:33 PM JOHNSON JOHN Director Sep 01 '24 Option Exercise 0.00 11,904 0 29,016 Sep 04 09:13 PM NEELS GUIDO J Director Sep 01 '24 Option Exercise 0.00 11,904 0 90,816 Sep 04 09:11 PM Levine Alan M Director Sep 01 '24 Option Exercise 0.00 11,904 0 40,816 Sep 04 08:58 PM Burke William P. Mr. Director Sep 01 '24 Option Exercise 0.00 11,904 0 28,557 Sep 04 08:52 PM THOMAS PAUL Director Sep 01 '24 Option Exercise 0.00 11,904 0 32,052 Sep 04 08:33 PM TYNDALL JOSEPH A. Director Sep 01 '24 Option Exercise 0.00 11,904 0 22,557 Sep 04 07:52 PM Wendell Amy McBride Director Sep 01 '24 Option Exercise 0.00 11,904 0 102,899 Sep 04 05:18 PM Donovan Michael Patrick Officer Aug 21 '24 Proposed Sale 12.42 28,003 347,810 Aug 21 04:31 PM GREG FREITAG Director Aug 13 '24 Proposed Sale 11.17 15,000 167,520 Aug 13 05:00 PM Zaderej Karen L. SENIOR ADVISOR Aug 12 '24 Proposed Sale 10.00 200,000 2,000,000 Aug 12 10:59 AM
